Edwin M. O'Connor

Mr. O’Connor’s recent representations include:

• The underwriters in Altair Engineering’s $156 million initial public offering
• Deciphera Pharmaceuticals in its $127.5 million initial public offering
• The underwriters in Arsanis’ $40 million initial public offering 
• argenx NV in its $100 million initial public offering and $266 million public follow-on offering
• The underwriters in G1 Therapeutics’ $116 million initial public offering
• The underwriters in Ovid Therapeutics’ $75 million initial public offering
• The underwriter in BeyondSpring’s $54 million initial public offering
• The underwriters as joint book-running managers in Albireo Pharmas’ $45 million follow-on public offering
• The underwriters in Syndax Pharmaceuticals’ $50 million follow-on public offering
• BeiGene in its $158 million initial public offering and $200 million and $800 million follow-on public offerings
• The underwriters in a $40 million follow-on offering for Innocoll
• The underwriters in Reata Pharmaceuticals' $60.5 million initial public offering
• The underwriters in Oncobiologics' $35 million initial public offering
• Voyager Therapeutics in its $70 million initial public offering
• The underwriters in the $281.5 million follow-on offering for DBV Technologies
• The underwriters in a $162 million secondary public offering by existing shareholders for Horizon Pharma, Inc.
• Inotek Pharmaceuticals Corporation in its $40 million initial public offering and a concurrent offering of $20 million offering of convertible senior notes, its $69 million follow-on offering, its $50 million offering of convertible senior notes, and its sale to Rocket Pharmaceuticals
• The underwriters in Trinseo’s $190 million initial public offering*
• The underwriters in Paycom Software’s $100 million initial public offering*

As Vice President in Goldman Sachs’ Investment Banking Division, Mr. O’Connor advised on several initial public offerings, including:

• Cornerstone OnDemand’s $137 million IPO
• RPX’s $160 million IPO
• Gigamon’s $128.5 million IPO
• Jive’s $120 million IPO
• Palo Alto Network’s $260 million IPO

* Denotes experience prior to joining Goodwin